Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies.
AUTOR(ES)
Asherson, R A
RESUMO
Procainamide is the commonest cause of a drug induced lupus syndrome. Long term administration of this compound may induce a variety of immunological abnormalities, including antinuclear antibodies. Uncommonly, 'lupus anticoagulants' have been demonstrated in the absence of other evidence of drug induced lupus. Details of a 67 year old man who developed not only drug induced lupus but also antiphospholipid antibodies which were associated with multiple pulmonary thromboemboli after the administration of procainamide are recorded.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1003727Documentos Relacionados
- Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.
- Quinine induced lupus-like syndrome and cardiolipin antibodies.
- Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.
- Natural antibody to procainamide and procainamide-induced systematic lupus erythematosus.
- Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies.